Medtech company raises millions and replaces majority of board members

Medtech company RSP Systems completed its third series B financing round, ensuring the firm a total amount of EUR 13.1 million (USD 14.96 million). The funding is to facilitate European launch of a non-invasive glucose monitoring device. At the same time, the company says goodbye to five in eight board members.

Photo: RSP Systems/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles